Pharmacom Biovet Inc (PHMB.PK)

PHMB.PK on OTC Markets Group

22 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PHMB.PK


PharmaCom BioVet Inc., formerly ABV Gold Inc., intends to introduce and further develop bone marrow transplantation and other cancer treatment procedures to benefit companion animals (canine and feline) that are diagnosed with lymphoma, other types of cancers and other diseases. The Company is introducing canine bone marrow... (more)
No analyst recommendations are available for PHMB.PK.


Beta: --
Market Cap (Mil.): $0.09
Shares Outstanding (Mil.): 856.09
Dividend: --
Yield (%): --


  PHMB.PK Industry Sector
P/E (TTM): -- 27.62 34.41
EPS (TTM): -0.99 -- --
ROI: -2,556.41 8.37 17.37
ROE: -2,556.41 12.88 18.18
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks